Hemostatic efficacy of Bipolar Thermofusion BiClamp in unilateral thyroidectomy
Phase 3
- Conditions
- Patient undergoing hemthyroidectomyThyroidectomyBleedingBiclamp
- Registration Number
- TCTR20150402001
- Lead Sponsor
- Faculty of Medicine Ramathibodi Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
- Age 20-60 years
- Diagnosis with thyroid mass: thyroid nodule, multinodular goiter, micropapillary carcinoma undergoing hemithyroidectomy at Ramathibodi Hospital
- Agree to sign consent
Exclusion Criteria
- Coagulation disorder or on antihemostasis drug such as ASA/warfarin
- Anaplastic thyroid carcinoma
- Patient requiring neck dissection
- Patient that bleeding cannot be stopped during surgery using regular method of bleeding (knot tying/thermal coagulating)
- Patient with previous thyroid operation
- Patient who denied to sign consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Drain amount after thyroidectomy 24, 48 hour after surgery cc
- Secondary Outcome Measures
Name Time Method Pain 4, 8, 12, 16, 24, 48 hours after surgery, 1 and 2 weeks after surgery VAS,Blood loss during surgery During surgery cc,Postoperative complication Postoperative Rates of complication such as hematoma, upper airway obstruction, hoarseness of voice, wound infecti,Length of hospital stay Postoperative Number of days postoperatively stay in hospital